Literature DB >> 18684964

Membrane protein Crry maintains homeostasis of the complement system.

Xiaobo Wu1, Dirk Spitzer, Dailing Mao, Stanford L Peng, Hector Molina, John P Atkinson.   

Abstract

Complement activation is tightly regulated to avoid excessive inflammatory and immune responses. Crry(-/-) is an embryonic lethal phenotype secondary to the maternal complement alternative pathway (AP) attacking a placenta deficient in this inhibitor. In this study, we demonstrate that Crry(-/-) mice could be rescued on a partial as well as on a complete factor B (fB)- or C3-deficient maternal background. The C3 and fB protein concentrations in Crry(-/-)C3(+/-) and Crry(-/-)fB(+/-) mice were substantially reduced for gene dosage secondary to enhanced AP turnover. Based on these observations, a breeding strategy featuring reduced maternal AP-activating capacity rescued the lethal phenotype. It led to a novel, stable line of Crry SKO mice carrying normal alleles for C3 and fB. Crry SKO mice also had accelerated C3 and fB turnover and therefore reduced AP- activating potential. These instructive results represent an example of a membrane regulatory protein being responsible for homeostasis of the complement system. They imply that there is constant turnover on cells of the AP pathway which functions as an immune surveillance system for pathogens and altered self.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684964      PMCID: PMC2580744          DOI: 10.4049/jimmunol.181.4.2732

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway.

Authors:  Dailing Mao; Xiaobo Wu; Christine Deppong; Lindzy D Friend; Gregory Dolecki; D Michael Nelson; Hector Molina
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

2.  p65: A C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor.

Authors:  W W Wong; D T Fearon
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

Review 3.  Molecular organization and function of the complement system.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Reaction mechanism of the alternative pathway of complement fixation.

Authors:  P J Lachmann; P Nicol
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

5.  Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects.

Authors:  H J Kang; L Bao; Y Xu; R J Quigg; P C Giclas; V M Holers
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

6.  ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement.

Authors:  Dirk Spitzer; Jacqueline Unsinger; Monica Bessler; John P Atkinson
Journal:  Mol Immunol       Date:  2004-02       Impact factor: 4.407

7.  Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.

Authors:  Tony Wyss-Coray; Fengrong Yan; Amy Hsiu-Ti Lin; John D Lambris; Jessy J Alexander; Richard J Quigg; Eliezer Masliah
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

8.  Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.

Authors:  Kirsten L Rose; Danielle Paixao-Cavalcante; Jennifer Fish; Anthony P Manderson; Talat H Malik; Anne E Bygrave; Tao Lin; Steven H Sacks; Mark J Walport; H Terence Cook; Marina Botto; Matthew C Pickering
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.

Authors:  M E Medof; T Kinoshita; V Nussenzweig
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  18 in total

1.  Properdin homeostasis requires turnover of the alternative complement pathway.

Authors:  Xiaobo Wu; Thomas Q Xu; John P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

2.  Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.

Authors:  Jennifer Laskowski; Brandon Renner; Moglie Le Quintrec; Sarah Panzer; Jonathan P Hannan; Danica Ljubanovic; Marieta M Ruseva; Dorin-Bogdan Borza; Alexandra H Antonioli; Matthew C Pickering; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2016-05-07       Impact factor: 10.612

3.  The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.

Authors:  Brandon Renner; Kathrin Coleman; Ryan Goldberg; Claudia Amura; Amanda Holland-Neidermyer; Kathryn Pierce; Heather N Orth; Hector Molina; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; V Michael Holers; Joshua M Thurman
Journal:  J Immunol       Date:  2010-07-30       Impact factor: 5.422

4.  C3-dependent mechanism of microglial priming relevant to multiple sclerosis.

Authors:  Valeria Ramaglia; Timothy R Hughes; Rossen M Donev; Marieta M Ruseva; Xiaobo Wu; Inge Huitinga; Frank Baas; James W Neal; B Paul Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

Review 5.  Complement activation, a threat to pregnancy.

Authors:  Guillermina Girardi
Journal:  Semin Immunopathol       Date:  2017-09-12       Impact factor: 9.623

6.  C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.

Authors:  Bangqing Yuan; Fenlan Fu; Shaokuan Huang; Chuangan Lin; Guang Yang; Kunlong Ma; Hui Shi; Zhao Yang
Journal:  Mol Neurobiol       Date:  2016-10-05       Impact factor: 5.590

7.  Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement.

Authors:  Elizabeth A Moulton; Paula Bertram; Nanhai Chen; R Mark L Buller; John P Atkinson
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

8.  Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.

Authors:  Fadi Fakhouri; Lubka Roumenina; François Provot; Marion Sallée; Sophie Caillard; Lionel Couzi; Marie Essig; David Ribes; Marie-Agnès Dragon-Durey; Frank Bridoux; Eric Rondeau; Veronique Frémeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 10.121

Review 9.  Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.

Authors:  R Alan Wilson; Patricia S Coulson
Journal:  Trends Parasitol       Date:  2009-08-28

10.  Cell surface complement regulators moderate experimental myasthenia gravis pathology.

Authors:  Linda L Kusner; Jose A Halperin; Henry J Kaminski
Journal:  Muscle Nerve       Date:  2012-10-05       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.